An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Asensus Surgical to Participate in the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright Bioconnect 2022 Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Asensus Surgical (NYSE American: ASXC) announced participation in two upcoming conferences. The 40th Annual J.P. Morgan Healthcare Conference will feature a virtual presentation on January 13, 2022, at 9:00 am ET. Additionally, the company will join the H.C. Wainwright Bioconnect 2022 Conference with a pre-recorded chat available from January 10, 2022, at 7:00 am ET. Both webcasts will be accessible on the investor relations page for 90 days.
Asensus aims to innovate surgical outcomes with its Senhance® Surgical System.
Positive
None.
Negative
None.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company’s virtual presentation will take place on Thursday, January 13, 2022 at 9:00 am Eastern Time.
In addition, the Company will participate in the H.C. Wainwright Bioconnect 2022 Conference during the week of January 10th. A pre-recorded fireside chat will be available on-demand beginning Monday, January 10, 2022 at 7:00 am Eastern Time.
Both conference webcasts will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replays of the webcasts will be archived on the website for approximately 90 days.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.
What is the date of Asensus Surgical's presentation at the J.P. Morgan Healthcare Conference?
Asensus Surgical's presentation at the J.P. Morgan Healthcare Conference is scheduled for January 13, 2022, at 9:00 am Eastern Time.
When will the pre-recorded fireside chat for the H.C. Wainwright Bioconnect 2022 Conference be available?
The pre-recorded fireside chat for the H.C. Wainwright Bioconnect 2022 Conference will be available on-demand starting January 10, 2022, at 7:00 am Eastern Time.
Where can I find the webcasts for Asensus Surgical's conference presentations?
The webcasts for Asensus Surgical's conference presentations will be available on their investor relations page.
What is the focus of Asensus Surgical's Senhance Surgical System?
Asensus Surgical's Senhance Surgical System focuses on digitizing the surgical interface to enhance outcomes through technology such as machine vision and deep learning.
